Free Trial
LON:FDBK

Feedback 11/4/2024 Earnings Report

Feedback logo
GBX 14 -0.50 (-3.45%)
As of 08/1/2025 07:06 AM Eastern

Feedback EPS Results

Actual EPS
-GBX 24.74
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Feedback Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Feedback Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Feedback Earnings Headlines

Vicat Q3 2024 Sales
Too busy to trade? Good.
Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at screens all day. Just enter near the close, exit the next morning—and move on. Some trades have hit 200%+ overnight.
See More Feedback Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Feedback? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Feedback and other key companies, straight to your email.

About Feedback

Feedback (LON:FDBK) (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical. Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients. By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers. Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance. CareLocker® is a patient-facing platform that gives patients access and control over their diagnostic and other clinical data. The Company has a number of growth opportunities domestically and internationally across a range of public and private healthcare markets including the NHS. Our highly scalable software-as-a-service (SaaS) based model is expected to provide increasing levels of revenue visibility as the Company grows its customer base.

View Feedback Profile

More Earnings Resources from MarketBeat